Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Public Health
Model for flu spread may not work in Covid-19: Study
Life Sciences Times
-
December 22, 2020
0
Biotech
AstraZeneca’s Fasenra gets DCGI nod for asthma treatment in India
Life Sciences Times
-
December 22, 2020
0
Public Health
Parents sweat it out over screen time, emotional health of kids
Life Sciences Times
-
December 22, 2020
0
Public Health
Covid situation in Germany continues to deteriorate
Life Sciences Times
-
December 22, 2020
0
Public Health
House panel subpoenas documents from Trump officials over interference with CDC
Life Sciences Times
-
December 21, 2020
0
Pharma
TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer
Life Sciences Times
-
December 21, 2020
0
Venture Capital
Nordic Capital and Astorg Invest in Pharmaceutical Technology and Advanced Analytics Company Cytel
Life Sciences Times
-
December 21, 2020
0
Life Sciences
Aceto Establishes Chemical Manufacturing and R&D Capabilities in the U.S. Through Acquisition of IsleChem
Life Sciences Times
-
December 21, 2020
0
Pharma
Servier to Acquire Cambridge-Based Agios Pharmaceuticals’ Oncology Business
Life Sciences Times
-
December 21, 2020
0
Medtech
Motility Medical Starts Human Trials for New Medical Device to Treat Constipation
Life Sciences Times
-
December 21, 2020
0
1
...
794
795
796
...
805
Page 795 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026